ACAN and Hyperglycemia: Additionally, gene (Figure 2C) and protein (Figure 2D) levels of chondrogenic markers including SOX9, type 2 collagen (Col II) and aggrecan (AGN) were significantly decreased, indicating the chondro-inhibitory nature of hyperglycemia.